CRISELDA MOLINA: Open Payments
NPI 1073109617 · EDINBURG, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$887 in 48 payments from 13 companies in 2025. Trend: 2023 $464 · 2024 $898 · 2025 $887
Food & beverage: $887
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 13 | $235 |
| ABBVIE INC. | 13 | $152 |
| AstraZeneca Pharmaceuticals LP | 6 | $121 |
| Astellas Pharma US Inc | 4 | $90 |
| Lilly USA, LLC | 2 | $50 |
| ViiV Healthcare Company | 2 | $49 |
| ABIOMED | 1 | $41 |
| Sumitomo Pharma America, Inc. | 2 | $40 |
| JAZZ PHARMACEUTICALS INC. | 1 | $38 |
| Bioventus LLC | 1 | $21 |
Products named: UBRELVY, Ozempic, AIRSUPRA, Veozah, JARDIANCE, APRETUDE, GEMTESA, EPIDIOLEX.
Industry payments across TX — which companies pay providers there.
